Comparison Halozyme Therapeutics (HALO) with Competitors
Halozyme Therapeutics (HALO) industry is Biotechnology.
Profit Margin
HALO39.83%
Industry-0.77%
Upside+40.60%
Operating Margin
HALO48.98%
Industry-2055.25%
Upside+2104.23%
Debt-to-Equity
HALO976.45%
Industry28.27%
Upside+3354.23%
Free Cash Flow Yield
HALO7.43%
Industry-1.75%
Upside+9.18%
P/E
HALO25.62
Industry-20.52
Upside+4614.08%
Forward P/E
HALO10.78
Industry16.35
Upside-34.07%
P/S
HALO5.90
Industry10.01
Upside-41.08%
P/B
HALO41.10
Industry5.15
Upside+698.56%